Latest News

by Robert MacKay, Friday, 26 November 2010 | Categories: Sexual Health

Botox may have more to offer than the stymieing of the ageing process...




by Robert MacKay, Thursday, 25 November 2010 | Categories: Slimming Pills

Orexigen’s weight loss drug Contrave, is next up on the chopping block but it might experience more mercy than the recent spurt of weight loss treatments that were refused approval this year...




by Robert MacKay, Friday, 19 November 2010 | Categories: General Health

Sharing the day with European Antibiotic Awareness day, the Department of Health yesterday launched a campaign that seeks to spread the awareness regarding the responsible use of antibiotics...




by Robert MacKay, Thursday, 18 November 2010 | Categories: Tesofensine

Neurosearch, a Danish biopharmaceutical company that researches drugs, which act on the central nervous system, had been preparing to commence phase III trials of their obesity drug Tesofensine...




by Robert MacKay, Wednesday, 17 November 2010 | Categories: Cholesterol

Merck’s latest experimental cholesterol drug, anacetrapib has yielded some interesting results in a study published with the New England Journal of Medicine...





 
We use cookies on this website. By using this site, you agree that we may store and access cookies on your device. Find out more Close